Kennedy's disease: pathogenesis and clinical approaches

Area of Science:

• Neuroscience
• Genetics
• Endocrinology

Background:

• Kennedy's disease, or spinal and bulbar muscular atrophy, is a progressive neurodegenerative disorder affecting lower motor neurons.
• It is characterized by a polyglutamine repeat expansion in the androgen receptor gene, uniquely affecting males due to X-linked inheritance.
• Recent research highlights the role of androgens in disease exacerbation, complicating potential therapeutic strategies.

Purpose of the Study:

• To review recent advances in Kennedy's disease research.
• To explore the pathogenic mechanisms, particularly the role of androgens.
• To discuss emerging treatment approaches.

Main Methods:

• Review of current scientific literature on Kennedy's disease.
• Analysis of pathogenic mechanisms involving polyglutamine repeat expansion and androgen receptor.
• Evaluation of proposed therapeutic strategies, including androgen-based treatments.

Main Results:

• Kennedy's disease is linked to polyglutamine expansion in the androgen receptor.
• Higher androgen levels in men may trigger motor neuron degeneration, while lower levels in women appear protective.
• This finding challenges the previous therapeutic consideration of testosterone treatment due to potential exacerbation.

Conclusions:

• Understanding the role of androgens is crucial for developing effective treatments for Kennedy's disease.
• Current research suggests a re-evaluation of testosterone-based therapies is necessary.
• Further investigation into the complex interplay between androgens and neurodegeneration is warranted.